Introduction {#s1}
============

Hereditary renal amyloidosis is a rare disease in which mutations of transthyretin, apolipoprotein AI, apolipoprotein AII, fibrinogen A α-chain and lysozyme have been identified in different pedigrees \[[@SFT007C1], [@SFT007C2]\]. More common forms of hereditary systemic amyloidosis can present as similar diseases \[[@SFT007C3]\]. Of these diseases, Finnish-type familial amyloidosis (FAF) is characterized by autosomal-dominant inheritance with predominant cranial involvement, particularly facial nerve involvement and corneal lattice dystrophy \[[@SFT007C4]\] and gelsolin-related amyloid deposition \[[@SFT007C5], [@SFT007C6]\]. Since its first description in 1969 \[[@SFT007C7]\], FAF has become established as an endemic disease in Finland, although a small number of individuals with this disease have also been reported in other European countries, the USA, Iran and Japan \[[@SFT007C8]\]. In addition, severe renal amyloidosis has been reported in a few FAF patients \[[@SFT007C9]--[@SFT007C11]\] homozygous for the G654A mutation of the gelsolin gene.

We report a Japanese mother and daughter with FAF who developed prominent nephropathy. Both patients were heterozygous for the G654A *gelsolin* mutation. We performed two renal biopsies 14 years apart and evaluated the natural history of the renal lesions.

Case report {#s2}
===========

Case 1 {#s2a}
------

A 21-year-old woman exhibited proteinuria during a regular medical examination. She developed hypertension (158/92 mmHg), and a 24-h urine collection showed that proteinuria had increased to 890 mg/day. She was admitted to our hospital. A renal biopsy was performed when she was 28 years old. Light microscopy demonstrated an increase in mesangial cell number and expanded mesangial areas due to amorphous deposits. These deposits were positive for direct fast scarlet staining but negative for silver staining. Capillary basement membrane thickening was evident ([Figure 1](#SFT007F1){ref-type="fig"}A). Small amounts of deposits were observed in the interstitium and the walls of the renal arterioles. Immunoglobulins, including λ and κ light chains and complement factors, were undetectable by immunofluorescence. Electron microscopy showed deposits comprising small non-branching fibrils 10 nm in diameter, consistent with amyloid fibril morphology. Although the capillaries and foot processes were substantially normal, we observed amyloid fibrils concentrated in the mesangial areas and along the lamina rara interna (the subendothelial layer closest to the endothelium) of the basement membrane ([Figure 1](#SFT007F1){ref-type="fig"}B). After diagnosis, angiotensin receptor blocker therapy (losartan, 50 mg/day) was initiated to treat the proteinuria and hypertension and was continued thereafter. Fig. 1.Renal biopsy findings of Case 1. (**A**) First biopsy: amyloid deposition is observed globally in the mesangial areas. Mesangial cells increased in number and the mesangial areas expanded as a result of deposition of amorphous material. In addition, thickening of the capillary basement membranes was observed. (Direct fast scarlet; original magnification ×400.) (**B**) First biopsy: electron microscopy revealed electron-dense deposits in the mesangial areas and lamina rara interna (the subendothelial layer closest to the endothelium). Glomerular tufts were normal in some areas. CP, capillary lumen; MS, mesangial area (original magnification ×2000). Bar = 1 µm. (**C**) Second biopsy: the amount of amyloid deposition had increased, the glomerular tuft area was enlarged with hypervascularity of the capillaries and focal segmental sclerotic lesions were formed (direct fast scarlet; original magnification ×400). (**D**) Second biopsy: aberrant *gelsolin* deposition increased, particularly in the glomerular tufts, revealing an increase in capillary loop thickness. Foot process fusions were observed extensively (original magnification ×2300). Bar = 1 µm. (D insert) The deposits consisted of randomly arranged fibrils 10 nm in diameter (Original magnification ×20 000). Bar = 100 nm. (**E**) Second biopsy: glomeruli revealed typical apple-green birefringence under polarized view (alkaline Congo red; original magnification ×110). (**F**) Second biopsy: all glomerular amyloid deposits were stained positively by a primary antibody for a purified low molecular weight subunit of FAF amyloid (anti-AGel; immunoperoxidase staining; original magnification ×80).

At 42 years of age (14 years after the first renal biopsy), she was readmitted with massive proteinuria and oedema. She had normal skin and no evidence of bilateral ptosis, blepharochalasis, rough facial folds or droopy lower lip. Neurological examination revealed diminished movement of the orbicularis oris and a positive ciliary sign. The other cranial nerves, limb muscular power and all tendon reflexes and nerve conduction velocities in the median and tibial nerves were normal. No autonomic dysfunction was observed. Slit lamp ophthalmological examination revealed a bilateral peripheral lattice line in the cornea without visual disturbances. Retinal examination was unremarkable with fluorescein angiography showing no evidence of peripheral retinal pigment clumping.

Serum creatinine and urea nitrogen concentrations were 0.7 mg/dL (61.9 µmol/L) and 5.9 g/dL (59 g/L), respectively. Serum total protein was 5.9 g/dL (59 g/L) and albumin concentration was 3.5 g/dL (35 g/L). The urinary sediment contained 10 white blood cells per high power field, with no red blood cells or granular casts. Her 24-h urine collection showed proteinuria of 4.400 mg/day and a creatinine clearance (C~Cr~) of 109 mL/min. The selectivity index was 0.12. The second renal biopsy demonstrated that amyloid deposition, particularly along the peripheral capillaries, had increased in a distinct diffuse global manner ([Figure 1](#SFT007F1){ref-type="fig"}C). Of note, electron microscopy revealed diffuse foot process effacement ([Figure 1](#SFT007F1){ref-type="fig"}D). Immunohistochemical studies of amyloid deposits using antibodies against amyloid A protein and transthyretin were negative.

Case 2 {#s2b}
------

The mother of Case 1 had a history of diabetes mellitus and acromegaly. She had been taking antihypertensive drugs. She was first examined at our hospital at 52 years of age and was shown subsequently to have moderate proteinuria (1700 mg in her 24-h urine collection). Renal function was almost normal \[serum creatinine level 0.8 mg/dL (70.7 µmol/L)\]. She had bilateral ptosis and blepharochalasis, bilateral facial weakness, rough facial folds and mild dysphagia. Limb muscular power was normal, although all the tendon reflexes were hypoactive. The light touch and vibratory sensations were impaired in the distal aspect of all limbs. Motor and sensory nerve conduction velocities in the bilateral median and tibial nerves were decreased. Slit lamp ophthalmological examination revealed bilateral corneal lattice dystrophy. The patient underwent a renal biopsy that revealed a similar pattern of amyloid deposits as observed with Case 1. Although her renal function remained stable over the following 10 years, we performed a second biopsy due to an increase in proteinuria. Many glomeruli were evidently enlarged, hyalinized and obsolescent in the specimen as a result of increased amyloid deposition.

The grandfather and younger sister of the patient also had proteinuria ([Figure 2](#SFT007F2){ref-type="fig"}A). As hereditary renal amyloidosis was tentatively diagnosed, amyloid fibril protein identification and causative gene abnormality analysis was performed. Amyloid fibril protein was extracted from biopsied renal tissue, and the amino acid sequences were determined using liquid chromatography--ion trap mass spectrometry \[[@SFT007C12]\]. This showed that the partial sequences of the extracted protein were consistent with the internal sequences of gelsolin (148--161, 162--166 and 231--243) \[[@SFT007C13]\]. Immunohistochemical analysis of the amyloid fibril protein was conducted as follows. Deparaffinized sections were stained by the avidin--biotin peroxidase technique and a rabbit antiserum primary antibody for a purified low-molecular-weight subunit of FAF amyloid (anti-AGel) and applied ([Figure 1](#SFT007F1){ref-type="fig"}F) \[[@SFT007C14]\]. All amyloid deposits in the biopsied samples from Cases 1 and 2 were immunolabelled specifically with this antibody ([Figure 1](#SFT007F1){ref-type="fig"}E and F). DNA analysis was performed for Cases 1 and 2, indicating a heterozygous G654A *gelsolin* mutation ([Figure 2](#SFT007F2){ref-type="fig"}B and C) \[[@SFT007C15], [@SFT007C16]\]. Fig. 2.(**A**) Family pedigree showing an autosomal dominant inheritance. Closed ones represent affected patients. (**B**) Restriction fragment length polymorphism analysis of the gelsolin gene in Cases 1 and 2. A 1160-bp subsequence of the gelsolin gene was amplified using PCR, as described previously \[[@SFT007C24]\]. The PCR product was digested with the endonuclease *Mun I* (New England Biolabs, Beverly, MA, USA) and electrophoresed. After enzyme digestion, the 116-bp DNA produced two fragments of 90 and 26 bp, indicating that the mutated gene was heterozygous. (**C**) DNA sequencing of Cases 1 and 2 revealed a heterozygous G654A mutation in the gelsolin gene.

Discussion {#s3}
==========

Few cases of FAF have been reported outside Finland. Of these, a Danish and a Czech family were shown to carry another mutation of gelsolin, G654T (D214Y) \[[@SFT007C17]\]. An American family carried a G580A (G194R) mutation, leading to renal amyloidosis with low eGFR and mild proteinuria \[[@SFT007C18]\]. In Japan, the six families with reported FAF \[[@SFT007C19], [@SFT007C20]\] have the common G654A (D214N) mutation of the gelsolin gene. The present cases with FAF were not related to the previously identified Japanese FAF families.

Renal amyloid deposition with nephrotic syndrome has been described in four patients with FAF homozygous for the G654A *gelsolin* mutation ([Table 1](#SFT007TB1){ref-type="table"}). Three of the four patients underwent renal transplantation for end-stage renal disease (ESRD) \[[@SFT007C11], [@SFT007C13]\]. In contrast, heterozygous patients frequently exhibited transient proteinuria \[[@SFT007C7], [@SFT007C9], [@SFT007C21], [@SFT007C22]\], which began at an advanced age and developed slowly. However, none of the patients had the nephrotic syndrome. Nevertheless, the heterozygous patients developed significant amyloid deposition in the renal glomeruli. Glomerular amyloid deposits were greater than those typically found in heterozygotes and similar to those found in homozygotes \[[@SFT007C10], [@SFT007C22]\]. Table 1.Summary of clinical, biological and histological data of familial amyloidosis Finnish-type patients^a^StudyPatient no.Age (years)/sexZygote/sequenceRenal onsetUrin protein (g/day)Cr (mg/dL)Renal clinical courseFacial paresisDistribution of amyloidFoot processes effacementMeretojya \[[@SFT007C7], [@SFT007C21]\] (1969, 1971)159/FNA43 yearsTransient proteiunuriaNANormal56 yearsGlomerularNAMeretojya *et al.* \[[@SFT007C21]\] (1971)267/FNA57  yearsTransient proteiunuriaNANormal58 yearsGlomerularNA3^b^79/MNA74 yearsTransient proteiunuriaNANormal74 yearsGlomerularNAMeretojya *et al.* \[[@SFT007C22]\] (1972)472/MNANATransient proteiunuria1.2NA+Glomerular--537/FNANormalNormal0.9Normal+Glomerular--656/FNANormalNormal0,8Normal+Glomerular--728/FHomo^c^28 years2--91.328 years NS → F/U+Glomerular+Maury et al \[[@SFT007C9]\] (1992)839/FHomo/G654A19 yearsNAESRD28 years NS → 36 years HD, KTx → 39years death19 yearsGlomerularNA935/FHomo/G654A13 yearsNAESRD21 years NS → 31 years PD → 32 years KTx24 yearsGlomerularNAArdalan *et al.* \[[@SFT007C10]\] (2007)1025/FHomo/G654A25 years3.60.825 years NS → F/U25 yearsGlomerular+Shoja *et al.* \[[@SFT007C11]\] (2009)1144/MHomo/G654ANA2-5ESRD29 years CKD → 35 years HD → 36 years KTx+GlomerularNACurrent Case 1^d^1242/FHetero/G654A21 years3.50.740 years Nephrotic-range proteinuriaNormalGlomerular+Current Case 2^d^1362/FHetero/G654ANA9.451.3651 years Nephrotic-range proteinuria62 yearsGlomerular+[^1][^2][^3][^4]

The reason for the development of distinctive renal involvement is unknown in our heterozygous cases. It has been postulated that the difference in clinical manifestation between homozygotes and heterozygotes may depend on the 'dosage effect' of aberrant gelsolin fragments \[[@SFT007C9]\]. Furthermore, a high plasma concentration of amyloidogenic gelsolin has been shown to facilitate increased polymerization of amyloid fibrils in glomerular tissues \[[@SFT007C9]\]. Nephrotic syndrome with homozygous FAF usually develops by the 20 s, followed by rapid progression to ESRD in the 30 s ([Table 1](#SFT007TB1){ref-type="table"}) \[[@SFT007C9]--[@SFT007C11]\]. In contrast, although proteinuria in Case 1 developed at 21 years, her renal function remained stable for \>20 years. In addition, greater amyloid protein production in homozygotes causes early onset of typical symptoms such as lattice corneal dystrophy and upper facial paresis ([Table 1](#SFT007TB1){ref-type="table"}). However, in Cases 1 and 2, these symptoms had a late onset, similar to that seen in heterozygotes reported previously \[[@SFT007C9], [@SFT007C23]\]. These observations are not consistent with the 'dosage effect' concept, and further studies are needed to clarify the underlying mechanisms.

In this and previous studies \[[@SFT007C7], [@SFT007C21], [@SFT007C22]\], amyloid deposits in the kidney with FAF were considered unexceptional. When hereditary renal amyloidosis is suspected based on family history, it is necessary to investigate the other typical symptoms of FAF, such as sagging facial skin and bilateral facial paresis, and search evidence for corneal lattice dystrophy by slit lamp ophthalmology. It is also necessary to identify the amyloid protein and analyse the gene. For prognostic prediction in heterozygous FAF, disease progression may be slow, but the possibility still remains that renal involvement may progress to nephrotic syndrome by 20--30 years of age.

In conclusion, to the best of our knowledge, this is the first report of a family with FAF demonstrating co-segregation of a heterozygous G654A *gelsolin* mutation and severe renal amyloidosis. To date, five different amyloid fibril proteins have been isolated from the affected family members of the patient. We showed that gelsolin-related FAF causes a hereditary type of renal amyloidosis.
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[^1]: ^a^NA, not available; Homo, homozygote; Hetero, heterozygote; ESRD, end-stage renal disease; NS, nephrotic syndrome; F/U, follow-up; HD, haemodialysis; PD, peritoneal dialysis; KTx, kidney transplantation indication; CKD, chronic kidney disease.

[^2]: ^b^This patient was diagnosed at the age of 74; it is possible that onset was considerably earlier.

[^3]: ^c^Since her parents had a consanguineous marriage and she suffered from severe amyloidosis, it was presumed that it is a homozygote.

[^4]: ^d^Data at the time of second hospitalization. Conversion factors for units: serum creatinine in mg/dL to mol/L, ×88.4.
